Lupin’s ivacaftor oral granules receives US FDA tentative approval: Our Bureau, Mumbai Friday, January 10, 2025, 11:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) announ ...

These generic granules are equivalent to Vertex Pharmaceuticals' 'Kalydeco' oral granules in the same strengths.

Ivacaftor Oral Granules, 25 mg, 50 mg and 75 mg per unit dose packet are indicated for cystic fibrosis treatment in patients ...

Lupin Ltd received tentative approval from the USFDA for its generic version of Ivacaftor oral granules, used for treating cystic fibrosis. The product, produced at Lupin's Nagpur facility, may ...

Lupin receives USFDA approval for its generic version of Ivacaftor oral granules, a treatment for cystic fibrosis. The ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA ® (elexacaftor ...

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

Lupin Ltd. signed a share subscription & shareholders agreement with Sunsure Solarpark Seventeen Pvt. and Sunsure Energy Pvt. to acquire equity investment up to 42.61% of equity share capital of ...

Vertex has won two cystic fibrosis approvals from the FDA, but the agency included high-level safety warnings.

These granules, available in 25 mg, 50 mg, and 75 mg per unit dose packets, are a generic equivalent of Kalydeco Oral ...

India has the potential to increase exports of organic products up to Rs 20,000 crore in the next three years, Commerce and ...